Literature DB >> 6187406

Rays of hope for rare ovarian cancers.

J S Scott.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6187406      PMCID： PMC1547181          DOI： 10.1136/bmj.286.6368.824

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  9 in total

Review 1.  The effect of cancer and its therapy upon fertility.

Authors:  H R Barber
Journal:  Int J Fertil       Date:  1981

2.  Natural history of dysgerminoma.

Authors:  G De Palo; S Pilotti; R Kenda; E Ratti; R Musumeci; C Mangioni; F Di Re; A Lattuada; U Conti; F Cefis; L Recanatini; S Carinelli; G Rossi
Journal:  Am J Obstet Gynecol       Date:  1982-08-01       Impact factor: 8.661

3.  Pregnancy following removal and chemotherapy of ovarian endodermal sinus tumor.

Authors:  J P Forney
Journal:  Obstet Gynecol       Date:  1978-09       Impact factor: 7.661

4.  Therapy of endodermal sinus tumor of the ovary.

Authors:  H Gallion; J R van Nagell; D F Powell; E S Donaldson; M Hanson
Journal:  Am J Obstet Gynecol       Date:  1979-10-15       Impact factor: 8.661

5.  Dysgerminoma: a review of 158 cases from the Emil Novak Ovarian Tumor Registry.

Authors:  A Gordon; D Lipton; J D Woodruff
Journal:  Obstet Gynecol       Date:  1981-10       Impact factor: 7.661

6.  Potential for cure in metastatic ovarian teratomas and dysgerminomas.

Authors:  E S Newlands; R H Begent; G J Rustin; K D Bagshawe
Journal:  Br J Obstet Gynaecol       Date:  1982-07

7.  Endodermal sinus tumour of the ovary: serum alpha-fetoprotein levels before and after treatment and during pregnancy. Case report.

Authors:  I D Duncan; J L Young
Journal:  Br J Obstet Gynaecol       Date:  1980-06

8.  Treatment of children with dysgerminoma of the ovary.

Authors:  M E Weinblatt; J A Ortega
Journal:  Cancer       Date:  1982-06-15       Impact factor: 6.860

9.  Chemotherapy of endodermal sinus tumour (yolk sac tumour) of the ovary: preliminary communication.

Authors:  E Wiltshaw; N F Gowing; R Stuart-Harris; S Raju; G H Barker
Journal:  J R Soc Med       Date:  1982-11       Impact factor: 18.000
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.